Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Elite Pharmaceuticals Cash from Investing (Quarterly): 0.0176M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0176M |
| June 30, 2024 | -1.663M |
| March 31, 2024 | -0.4036M |
| December 31, 2023 | -0.406M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.5362M |
| December 31, 2022 | -0.0007M |
| September 30, 2022 | -5.105M |
| June 30, 2022 | -0.0946M |
| March 31, 2022 | -0.2642M |
| December 31, 2021 | -0.0821M |
| September 30, 2021 | -0.1474M |
| June 30, 2021 | -0.005M |
| March 31, 2021 | -0.1849M |
| December 31, 2020 | -0.0377M |
| September 30, 2020 | -0.0774M |
| June 30, 2020 | 0.0373M |
| March 31, 2020 | -0.0318M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0002M |
| June 30, 2019 | -0.003M |
| March 31, 2019 | 0.35M |
| December 31, 2018 | -0.0191M |
| September 30, 2018 | 0.1786M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.1786M |
| March 31, 2018 | 0.1018M |
| December 31, 2017 | 0.0852M |
| September 30, 2017 | -0.126M |
| June 30, 2017 | -0.3358M |
| March 31, 2017 | -0.2929M |
| December 31, 2016 | -0.2927M |
| September 30, 2016 | -0.2349M |
| June 30, 2016 | -0.2845M |
| March 31, 2016 | -0.5708M |
| December 31, 2015 | 0.0455M |
| September 30, 2015 | -0.7072M |
| June 30, 2015 | -0.7163M |
| March 31, 2015 | -0.5988M |
| December 31, 2014 | -0.3844M |
| September 30, 2014 | -0.3778M |
| June 30, 2014 | 4.240M |
| March 31, 2014 | -0.0643M |
| December 31, 2013 | -0.317M |
| September 30, 2013 | -0.0415M |
| June 30, 2013 | -0.1349M |
| March 31, 2013 | 0.0542M |
| December 31, 2012 | -0.1131M |
| September 30, 2012 | -0.0611M |
| June 30, 2012 | -0.0719M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.105M
Minimum
Sep 2022
0.0373M
Maximum
Jun 2020
-0.4493M
Average
-0.0798M
Median
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -16.16M |
| BioCardia Inc | -0.002M |
| Zevra Therapeutics Inc | -31.35M |
| Verrica Pharmaceuticals Inc | -0.016M |
| Terns Pharmaceuticals Inc | 31.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.457M |
| Cash from Financing (Quarterly) | -0.3207M |
| Free Cash Flow | 1.685M |
| Free Cash Flow Per Share (Quarterly) | 0.0013 |
| Free Cash Flow to Equity (Quarterly) | 1.595M |
| Free Cash Flow to Firm (Quarterly) | 1.653M |
| Free Cash Flow Yield | 0.26% |